Bristol-Myers to Buy Karuna Therapeutics for $14B

6
Comment
Favorite

Bristol-Myers to Buy Karuna Therapeutics for $14B

Seeking Alpha2023-12-22

Karuna Therapeutics surged over 48% while Bristol-Myers Squibb slid nearly 3% in premarket trading.Bristol Myers Squibb (NYSE: BMY) agreed to buy neuroscience-drug firm Karuna Therapeutics (NASDAQ: ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment

No comments yet

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1187828956?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-12-22 20:01","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"1187828956","market":"us","top_or_hot":-1,"title":"Bristol-Myers to Buy Karuna Therapeutics for $14B","media":"Seeking Alpha","content":"<div>\n<p>Karuna Therapeutics surged over 48% while Bristol-Myers Squibb slid nearly 3% in premarket trading.Bristol Myers Squibb (NYSE: BMY) agreed to buy neuroscience-drug firm Karuna Therapeutics (NASDAQ: ...</p>\n\n<a href=\"https://seekingalpha.com/news/4049597-bristol-myers-to-buy-karuna-therapeutics-for-14b-wsj\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bristol-Myers to Buy Karuna Therapeutics for $14B</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBristol-Myers to Buy Karuna Therapeutics for $14B\n</h2>\n\n<h4 class=\"meta\">\n\n\n2023-12-22 20:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4049597-bristol-myers-to-buy-karuna-therapeutics-for-14b-wsj><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Karuna Therapeutics surged over 48% while Bristol-Myers Squibb slid nearly 3% in premarket trading.Bristol Myers Squibb (NYSE: BMY) agreed to buy neuroscience-drug firm Karuna Therapeutics (NASDAQ: ...</p>\n\n<a href=\"https://seekingalpha.com/news/4049597-bristol-myers-to-buy-karuna-therapeutics-for-14b-wsj\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KRTX","symbol_name":"Karuna Therapeutics","start_time":0,"source_url":"https://seekingalpha.com/news/4049597-bristol-myers-to-buy-karuna-therapeutics-for-14b-wsj","article_id":"1187828956","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1187828956","pubTimestamp":1703246477,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"$Karuna Therapeutics$ surged over 48% while $Bristol-Myers Squibb$ slid nearly 3% in premarket trading.Bristol Myers Squibb  agreed to buy neuroscience-drug firm Karuna Therapeutics  for $14 billion. Bristol will pay $33 a share for Karuna  and its experimental schizophrenia drug, according to a WSJ report on Friday. The deal is expected to close in 1H of next year and includes $1.3 billion in cash that Karuna has on hand.","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"KRTX":"Karuna Therapeutics","BMY":"施贵宝"},"translate_title":"百时美施贵宝将以140亿美元收购卡鲁纳治疗公司","themeId":"c5bbfdf5f7964880af97c1d6f417052c","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"BMY":1.1,"KRTX":1.1},"content_text":"Karuna Therapeutics surged over 48% while Bristol-Myers Squibb slid nearly 3% in premarket trading.Bristol Myers Squibb (NYSE: BMY) agreed to buy neuroscience-drug firm Karuna Therapeutics (NASDAQ: KRTX) for $14 billion. Bristol will pay $33 a share for Karuna (KRTX) and its experimental schizophrenia drug, according to a WSJ report on Friday. The deal is expected to close in 1H of next year and includes $1.3 billion in cash that Karuna has on hand.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":6,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}